Showing 391-400 of 10581 results for "".
The Future of Oral SERDs: Combination Strategies
https://reachmd.com/programs/cme/the-future-of-oral-serds-combination-strategies/39801/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
https://reachmd.com/programs/cme/the-hidden-threat-transforming-ckd-care-across-the-diabetes-spectrum/36523/Learn to identify hidden CKD risks in diabetes. Early diagnosis and new agents are reshaping T2D care today, with trials guiding future T1D treatment.The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
https://reachmd.com/programs/cme/the-underestimated-consequences-of-uncontrolled-gout-renal-and-cardiovascular-implications/15702/Our experts offer tips to rapidly and sustainably lower serum uric acid levels to <6 mg/dL in your patients with CKD & uncontrolled refractory gout.Epilepsy Essentials: Practical Uses of EEG in the Operating Room
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-practical-uses-of-eeg-in-the-operating-room/37660/Intraoperative EEG monitoring of brain function during surgical procedures acquires real-time electrophysiologic signals and provides immediate feedback to the surgeon.Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
https://reachmd.com/programs/cme/treat-target-transform-applying-treat-to-target-principles-in-the-management-of-generalized-myasthenia-gravis-gmg/39980/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Progress in Breast Cancer Care: Translating SABCS Data Into Practice
https://reachmd.com/programs/cme/progress-in-breast-cancer-care-translating-sabcs-data-into-practice/48989/Learn to integrate the latest data on ADCs in breast cancer into clinical practice, expand treatment options, and apply emerging evidence in real-world care.Advancing Cardiology and Heart Surgery Through a History of Collaboration
https://reachmd.com/programs/medical-industry-feature/advancing-cardiology-and-heart-surgery-through-a-history-of-collaboration/29915/Hear Dr. Craig Smith discuss the evolution of cardiac care, including the life-saving advancements he’s seen during his four-decade career as a cardiac surgeon.Are We Prepared for MACRA and the Quality Payment Program? The Survey Says . . .
https://reachmd.com/programs/perspectives-ama/are-we-prepared-for-macra-and-the-quality-payment-program-survey-says/9693/Guest experts from the AMA and KPMG share their survey results revealing how prepared physicians really are for MACRA and the QPP.Reconstructive Surgery for Pelvic Floor Disorders: Benefits vs Risks for Sexual Health
https://reachmd.com/programs/sexmed/reconstructive-surgery-pelvic-floor-disorders-benefits-vs-risks-sexual-health/7521/For women in their 40's and 50's, approximately one in four will develop a pelvic floor disorder such as urinary incontinence. By the age of 80, that prevalence rises to more than 50 percent. The struggle with a pelvic floor disorder has lasting effects on a woman's sexual health, leading to numerouPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 3
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-3/56871/In the third installment of a nine-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, analyze key study results, highlighting improvements in body surface area, lesion characteristics, and quality of life with adjunctive skincare use.1 D